Related Experiment Videos
Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta
S Chakrabarty1, Y Jan, M G Brattain
1Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030.
Abstract:
We have recently characterized the growth-inhibitory and cellular responses [carcinoembryonic antigen (CEA) secretion, protein secretion, protein expression, fibronectin and laminin synthesis] of the human colon carcinoma MOSER cell line to transforming growth factor-beta (TGF-beta) (Cancer Res., 47: 2950, 1987; 48: 4059, 1988). We have also recently isolated a subline (MOSER R2) from the parental MOSER cells which, unlike the parental line, is relatively resistant to the growth-inhibitory effect of TGF-beta (Biochem. Biophys. Res. Commun., 150: 711, 1988). We now report on the characterization of the cellular responses of this resistant MOSER R2 subline to TGF-beta and compare its responses to that of the highly growth-inhibition-sensitive MOSER cell line. In view of the reported relationship between CEA expression and differentiation in colon cancer and the ability of colon-derived substrata material to modulate the phenotypic properties of colon cancer cells, additional characterization and direct comparison of the effects of TGF-beta on the two cell lines were also performed with respect to (a) cellular expression of CEA and CEA cross-reactive glycoproteins; and (b) colon-derived substrata material. Unlike the growth-inhibition-sensitive MOSER cells, TGF-beta had no effects on fibronectin/laminin synthesis nor on the cellular morphology of the resistant MOSER R2 cells. TGF-beta was also unable to modulate protein secretion and deposition of substrata material by these cells. However, several other responses of the resistant cells to TGF-beta were found to be similar to that of the sensitive MOSER cells. These responses include: (a) a prolonged and stable secretion of CEA; (b) a prolonged and stable induction of elevated cellular expression of CEA and CEA cross-reactive glycoproteins; and (c) enhancement of the expression of three cellular proteins with molecular weights corresponding to 52,000, 48,000, and 42,000. We further report that the differences observed in the responses to TGF-beta in the two cell lines were not due to differences in TGF-beta binding or other receptor parameters such as the expression of distinct TGF-beta receptor subspecies.
Insights
Transforming growth factor-beta (TGF-beta) affects colon cancer cells differently. A resistant subline (MOSER R2) showed altered responses to TGF-beta, impacting CEA secretion and protein expression but not fibronectin/laminin synthesis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Transforming growth factor-beta (TGF-beta) influences cellular processes in colon carcinoma.
- A TGF-beta-resistant subline, MOSER R2, was derived from the MOSER colon carcinoma cell line.
- Understanding differential cellular responses to TGF-beta is crucial for cancer research.
Purpose of the Study:
- To characterize the cellular responses of the TGF-beta-resistant MOSER R2 subline to TGF-beta.
- To compare the TGF-beta responses of MOSER R2 cells with the sensitive parental MOSER cells.
- To investigate the effects of TGF-beta on carcinoembryonic antigen (CEA) expression and extracellular matrix synthesis in both cell lines.
Main Methods:
- Cell culture of human colon carcinoma MOSER and MOSER R2 subline.
- Treatment with transforming growth factor-beta (TGF-beta).
- Analysis of cellular morphology, fibronectin/laminin synthesis, protein secretion, and CEA expression.
Main Results:
- TGF-beta did not affect fibronectin/laminin synthesis, cellular morphology, or protein secretion in MOSER R2 cells.
- MOSER R2 cells exhibited prolonged, stable secretion and elevated cellular expression of CEA and CEA cross-reactive glycoproteins upon TGF-beta treatment.
- TGF-beta enhanced the expression of specific cellular proteins (52, 50, and 42 kDa) in MOSER R2 cells, similar to parental cells.
- Differences in cellular responses were not attributed to TGF-beta receptor binding or expression.
Conclusions:
- The MOSER R2 subline displays distinct cellular responses to TGF-beta compared to the sensitive MOSER cell line.
- TGF-beta can modulate CEA expression and secretion independently of its growth-inhibitory effects in colon cancer cells.
- These findings highlight the complex role of TGF-beta signaling in colon cancer cell phenotypes and differentiation markers.